 | • レポートコード：QFJ1-5576 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、痔瘻薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（下剤、抗生物質、局所硝酸塩、カルシウムチャネル遮断薬、オナボツリヌムトキシンA注射剤、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・痔瘻薬の市場動向 ・企業の競争状況、市場シェア ・痔瘻薬の種類別市場規模と予測2016-2027（下剤、抗生物質、局所硝酸塩、カルシウムチャネル遮断薬、オナボツリヌムトキシンA注射剤、その他） ・痔瘻薬の用途別市場規模と予測2016-2027（病院、診療所、その他） ・痔瘻薬の北米市場規模2016-2027（アメリカ、カナダ） ・痔瘻薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・痔瘻薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・痔瘻薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・痔瘻薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、AbbVie、Bayer、Novartis、Mylan、Teva Pharmaceuticals、Bausch Health、Takeda、Kyowa Kirin (ProStrakan)、Boiron、Roche、Hikma Pharmaceuticals、TWi Pharmaceuticals、Sanofi、Sun Pharmaceutical、Bristol Myers、Akorn、Dr. Reddys、Lupin、Advanz Pharmaceutical、Aurobindo pharma、Baxter International） ・結論 |
Medications for anal fissures such as topical nitrates, calcium channel blockers, and onabotulinumtoxinA injections are considered first-line therapy. These medications reduce anal sphincter tone, which, in turn, increases anodermal blood flow. Antibiotics may be necessary for the treatment of anal fistulas
Market Analysis and Insights: Global Anal Fistula Drugs Market
The global Anal Fistula Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anal Fistula Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anal Fistula Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anal Fistula Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anal Fistula Drugs market.
Global Anal Fistula Drugs Scope and Market Size
Anal Fistula Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anal Fistula Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Laxatives
Antibiotics
Topical Nitrates
Calcium Channel Blockers
OnabotulinumtoxinA Injections
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
AbbVie
Bayer
Novartis
Mylan
Teva Pharmaceuticals
Bausch Health
Takeda
Kyowa Kirin (ProStrakan)
Boiron
Roche
Hikma Pharmaceuticals
TWi Pharmaceuticals
Sanofi
Sun Pharmaceutical
Bristol Myers
Akorn
Dr. Reddys
Lupin
Advanz Pharmaceutical
Aurobindo pharma
Baxter International
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anal Fistula Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Laxatives
1.2.3 Antibiotics
1.2.4 Topical Nitrates
1.2.5 Calcium Channel Blockers
1.2.6 OnabotulinumtoxinA Injections
1.2.7 Others
1.3 Market by Application
1.3.1 Global Anal Fistula Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anal Fistula Drugs Market Perspective (2016-2027)
2.2 Anal Fistula Drugs Growth Trends by Regions
2.2.1 Anal Fistula Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anal Fistula Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Anal Fistula Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Anal Fistula Drugs Industry Dynamic
2.3.1 Anal Fistula Drugs Market Trends
2.3.2 Anal Fistula Drugs Market Drivers
2.3.3 Anal Fistula Drugs Market Challenges
2.3.4 Anal Fistula Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anal Fistula Drugs Players by Revenue
3.1.1 Global Top Anal Fistula Drugs Players by Revenue (2016-2021)
3.1.2 Global Anal Fistula Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Anal Fistula Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anal Fistula Drugs Revenue
3.4 Global Anal Fistula Drugs Market Concentration Ratio
3.4.1 Global Anal Fistula Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anal Fistula Drugs Revenue in 2020
3.5 Anal Fistula Drugs Key Players Head office and Area Served
3.6 Key Players Anal Fistula Drugs Product Solution and Service
3.7 Date of Enter into Anal Fistula Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anal Fistula Drugs Breakdown Data by Type
4.1 Global Anal Fistula Drugs Historic Market Size by Type (2016-2021)
4.2 Global Anal Fistula Drugs Forecasted Market Size by Type (2022-2027)
5 Anal Fistula Drugs Breakdown Data by Application
5.1 Global Anal Fistula Drugs Historic Market Size by Application (2016-2021)
5.2 Global Anal Fistula Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anal Fistula Drugs Market Size (2016-2027)
6.2 North America Anal Fistula Drugs Market Size by Type
6.2.1 North America Anal Fistula Drugs Market Size by Type (2016-2021)
6.2.2 North America Anal Fistula Drugs Market Size by Type (2022-2027)
6.2.3 North America Anal Fistula Drugs Market Size by Type (2016-2027)
6.3 North America Anal Fistula Drugs Market Size by Application
6.3.1 North America Anal Fistula Drugs Market Size by Application (2016-2021)
6.3.2 North America Anal Fistula Drugs Market Size by Application (2022-2027)
6.3.3 North America Anal Fistula Drugs Market Size by Application (2016-2027)
6.4 North America Anal Fistula Drugs Market Size by Country
6.4.1 North America Anal Fistula Drugs Market Size by Country (2016-2021)
6.4.2 North America Anal Fistula Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anal Fistula Drugs Market Size (2016-2027)
7.2 Europe Anal Fistula Drugs Market Size by Type
7.2.1 Europe Anal Fistula Drugs Market Size by Type (2016-2021)
7.2.2 Europe Anal Fistula Drugs Market Size by Type (2022-2027)
7.2.3 Europe Anal Fistula Drugs Market Size by Type (2016-2027)
7.3 Europe Anal Fistula Drugs Market Size by Application
7.3.1 Europe Anal Fistula Drugs Market Size by Application (2016-2021)
7.3.2 Europe Anal Fistula Drugs Market Size by Application (2022-2027)
7.3.3 Europe Anal Fistula Drugs Market Size by Application (2016-2027)
7.4 Europe Anal Fistula Drugs Market Size by Country
7.4.1 Europe Anal Fistula Drugs Market Size by Country (2016-2021)
7.4.2 Europe Anal Fistula Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anal Fistula Drugs Market Size (2016-2027)
8.2 Asia-Pacific Anal Fistula Drugs Market Size by Type
8.2.1 Asia-Pacific Anal Fistula Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anal Fistula Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anal Fistula Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Anal Fistula Drugs Market Size by Application
8.3.1 Asia-Pacific Anal Fistula Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anal Fistula Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anal Fistula Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Anal Fistula Drugs Market Size by Region
8.4.1 Asia-Pacific Anal Fistula Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anal Fistula Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anal Fistula Drugs Market Size (2016-2027)
9.2 Latin America Anal Fistula Drugs Market Size by Type
9.2.1 Latin America Anal Fistula Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Anal Fistula Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Anal Fistula Drugs Market Size by Type (2016-2027)
9.3 Latin America Anal Fistula Drugs Market Size by Application
9.3.1 Latin America Anal Fistula Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Anal Fistula Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Anal Fistula Drugs Market Size by Application (2016-2027)
9.4 Latin America Anal Fistula Drugs Market Size by Country
9.4.1 Latin America Anal Fistula Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Anal Fistula Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anal Fistula Drugs Market Size (2016-2027)
10.2 Middle East & Africa Anal Fistula Drugs Market Size by Type
10.2.1 Middle East & Africa Anal Fistula Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anal Fistula Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anal Fistula Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Anal Fistula Drugs Market Size by Application
10.3.1 Middle East & Africa Anal Fistula Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anal Fistula Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anal Fistula Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Anal Fistula Drugs Market Size by Country
10.4.1 Middle East & Africa Anal Fistula Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anal Fistula Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Anal Fistula Drugs Introduction
11.1.4 Pfizer Revenue in Anal Fistula Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Anal Fistula Drugs Introduction
11.2.4 AbbVie Revenue in Anal Fistula Drugs Business (2016-2021)
11.2.5 AbbVie Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Anal Fistula Drugs Introduction
11.3.4 Bayer Revenue in Anal Fistula Drugs Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Anal Fistula Drugs Introduction
11.4.4 Novartis Revenue in Anal Fistula Drugs Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Anal Fistula Drugs Introduction
11.5.4 Mylan Revenue in Anal Fistula Drugs Business (2016-2021)
11.5.5 Mylan Recent Development
11.6 Teva Pharmaceuticals
11.6.1 Teva Pharmaceuticals Company Details
11.6.2 Teva Pharmaceuticals Business Overview
11.6.3 Teva Pharmaceuticals Anal Fistula Drugs Introduction
11.6.4 Teva Pharmaceuticals Revenue in Anal Fistula Drugs Business (2016-2021)
11.6.5 Teva Pharmaceuticals Recent Development
11.7 Bausch Health
11.7.1 Bausch Health Company Details
11.7.2 Bausch Health Business Overview
11.7.3 Bausch Health Anal Fistula Drugs Introduction
11.7.4 Bausch Health Revenue in Anal Fistula Drugs Business (2016-2021)
11.7.5 Bausch Health Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Anal Fistula Drugs Introduction
11.8.4 Takeda Revenue in Anal Fistula Drugs Business (2016-2021)
11.8.5 Takeda Recent Development
11.9 Kyowa Kirin (ProStrakan)
11.9.1 Kyowa Kirin (ProStrakan) Company Details
11.9.2 Kyowa Kirin (ProStrakan) Business Overview
11.9.3 Kyowa Kirin (ProStrakan) Anal Fistula Drugs Introduction
11.9.4 Kyowa Kirin (ProStrakan) Revenue in Anal Fistula Drugs Business (2016-2021)
11.9.5 Kyowa Kirin (ProStrakan) Recent Development
11.10 Boiron
11.10.1 Boiron Company Details
11.10.2 Boiron Business Overview
11.10.3 Boiron Anal Fistula Drugs Introduction
11.10.4 Boiron Revenue in Anal Fistula Drugs Business (2016-2021)
11.10.5 Boiron Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Anal Fistula Drugs Introduction
11.11.4 Roche Revenue in Anal Fistula Drugs Business (2016-2021)
11.11.5 Roche Recent Development
11.12 Hikma Pharmaceuticals
11.12.1 Hikma Pharmaceuticals Company Details
11.12.2 Hikma Pharmaceuticals Business Overview
11.12.3 Hikma Pharmaceuticals Anal Fistula Drugs Introduction
11.12.4 Hikma Pharmaceuticals Revenue in Anal Fistula Drugs Business (2016-2021)
11.12.5 Hikma Pharmaceuticals Recent Development
11.13 TWi Pharmaceuticals
11.13.1 TWi Pharmaceuticals Company Details
11.13.2 TWi Pharmaceuticals Business Overview
11.13.3 TWi Pharmaceuticals Anal Fistula Drugs Introduction
11.13.4 TWi Pharmaceuticals Revenue in Anal Fistula Drugs Business (2016-2021)
11.13.5 TWi Pharmaceuticals Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Details
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Anal Fistula Drugs Introduction
11.14.4 Sanofi Revenue in Anal Fistula Drugs Business (2016-2021)
11.14.5 Sanofi Recent Development
11.15 Sun Pharmaceutical
11.15.1 Sun Pharmaceutical Company Details
11.15.2 Sun Pharmaceutical Business Overview
11.15.3 Sun Pharmaceutical Anal Fistula Drugs Introduction
11.15.4 Sun Pharmaceutical Revenue in Anal Fistula Drugs Business (2016-2021)
11.15.5 Sun Pharmaceutical Recent Development
11.16 Bristol Myers
11.16.1 Bristol Myers Company Details
11.16.2 Bristol Myers Business Overview
11.16.3 Bristol Myers Anal Fistula Drugs Introduction
11.16.4 Bristol Myers Revenue in Anal Fistula Drugs Business (2016-2021)
11.16.5 Bristol Myers Recent Development
11.17 Akorn
11.17.1 Akorn Company Details
11.17.2 Akorn Business Overview
11.17.3 Akorn Anal Fistula Drugs Introduction
11.17.4 Akorn Revenue in Anal Fistula Drugs Business (2016-2021)
11.17.5 Akorn Recent Development
11.18 Dr. Reddys
11.18.1 Dr. Reddys Company Details
11.18.2 Dr. Reddys Business Overview
11.18.3 Dr. Reddys Anal Fistula Drugs Introduction
11.18.4 Dr. Reddys Revenue in Anal Fistula Drugs Business (2016-2021)
11.18.5 Dr. Reddys Recent Development
11.18 Lupin
.1 Lupin Company Details
.2 Lupin Business Overview
.3 Lupin Anal Fistula Drugs Introduction
.4 Lupin Revenue in Anal Fistula Drugs Business (2016-2021)
.5 Lupin Recent Development
11.20 Advanz Pharmaceutical
11.20.1 Advanz Pharmaceutical Company Details
11.20.2 Advanz Pharmaceutical Business Overview
11.20.3 Advanz Pharmaceutical Anal Fistula Drugs Introduction
11.20.4 Advanz Pharmaceutical Revenue in Anal Fistula Drugs Business (2016-2021)
11.20.5 Advanz Pharmaceutical Recent Development
11.21 Aurobindo pharma
11.21.1 Aurobindo pharma Company Details
11.21.2 Aurobindo pharma Business Overview
11.21.3 Aurobindo pharma Anal Fistula Drugs Introduction
11.21.4 Aurobindo pharma Revenue in Anal Fistula Drugs Business (2016-2021)
11.21.5 Aurobindo pharma Recent Development
11.22 Baxter International
11.22.1 Baxter International Company Details
11.22.2 Baxter International Business Overview
11.22.3 Baxter International Anal Fistula Drugs Introduction
11.22.4 Baxter International Revenue in Anal Fistula Drugs Business (2016-2021)
11.22.5 Baxter International Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anal Fistula Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Laxatives
Table 3. Key Players of Antibiotics
Table 4. Key Players of Topical Nitrates
Table 5. Key Players of Calcium Channel Blockers
Table 6. Key Players of OnabotulinumtoxinA Injections
Table 7. Key Players of Others
Table 8. Global Anal Fistula Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Anal Fistula Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Anal Fistula Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Anal Fistula Drugs Market Share by Regions (2016-2021)
Table 12. Global Anal Fistula Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Anal Fistula Drugs Market Share by Regions (2022-2027)
Table 14. Anal Fistula Drugs Market Trends
Table 15. Anal Fistula Drugs Market Drivers
Table 16. Anal Fistula Drugs Market Challenges
Table 17. Anal Fistula Drugs Market Restraints
Table 18. Global Anal Fistula Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Anal Fistula Drugs Market Share by Players (2016-2021)
Table 20. Global Top Anal Fistula Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anal Fistula Drugs as of 2020)
Table 21. Ranking of Global Top Anal Fistula Drugs Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Anal Fistula Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Anal Fistula Drugs Product Solution and Service
Table 25. Date of Enter into Anal Fistula Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Anal Fistula Drugs Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Anal Fistula Drugs Revenue Market Share by Type (2016-2021)
Table 29. Global Anal Fistula Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Anal Fistula Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Anal Fistula Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Anal Fistula Drugs Revenue Market Share by Application (2016-2021)
Table 33. Global Anal Fistula Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Anal Fistula Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Anal Fistula Drugs Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Anal Fistula Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Anal Fistula Drugs Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Anal Fistula Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Anal Fistula Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Anal Fistula Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Anal Fistula Drugs Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Anal Fistula Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Anal Fistula Drugs Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Anal Fistula Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Anal Fistula Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Anal Fistula Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anal Fistula Drugs Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Anal Fistula Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Anal Fistula Drugs Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Anal Fistula Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Anal Fistula Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Anal Fistula Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Anal Fistula Drugs Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Anal Fistula Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Anal Fistula Drugs Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Anal Fistula Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Anal Fistula Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Anal Fistula Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anal Fistula Drugs Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Anal Fistula Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Anal Fistula Drugs Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Anal Fistula Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Anal Fistula Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Anal Fistula Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Anal Fistula Drugs Product
Table 68. Pfizer Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. AbbVie Company Details
Table 71. AbbVie Business Overview
Table 72. AbbVie Anal Fistula Drugs Product
Table 73. AbbVie Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 74. AbbVie Recent Development
Table 75. Bayer Company Details
Table 76. Bayer Business Overview
Table 77. Bayer Anal Fistula Drugs Product
Table 78. Bayer Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 79. Bayer Recent Development
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Anal Fistula Drugs Product
Table 83. Novartis Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 84. Novartis Recent Development
Table 85. Mylan Company Details
Table 86. Mylan Business Overview
Table 87. Mylan Anal Fistula Drugs Product
Table 88. Mylan Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 89. Mylan Recent Development
Table 90. Teva Pharmaceuticals Company Details
Table 91. Teva Pharmaceuticals Business Overview
Table 92. Teva Pharmaceuticals Anal Fistula Drugs Product
Table 93. Teva Pharmaceuticals Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 94. Teva Pharmaceuticals Recent Development
Table 95. Bausch Health Company Details
Table 96. Bausch Health Business Overview
Table 97. Bausch Health Anal Fistula Drugs Product
Table 98. Bausch Health Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 99. Bausch Health Recent Development
Table 100. Takeda Company Details
Table 101. Takeda Business Overview
Table 102. Takeda Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 103. Takeda Recent Development
Table 104. Kyowa Kirin (ProStrakan) Company Details
Table 105. Kyowa Kirin (ProStrakan) Business Overview
Table 106. Kyowa Kirin (ProStrakan) Anal Fistula Drugs Product
Table 107. Kyowa Kirin (ProStrakan) Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 108. Kyowa Kirin (ProStrakan) Recent Development
Table 109. Boiron Company Details
Table 110. Boiron Business Overview
Table 111. Boiron Anal Fistula Drugs Product
Table 112. Boiron Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 113. Boiron Recent Development
Table 114. Roche Company Details
Table 115. Roche Business Overview
Table 116. Roche Anal Fistula Drugs Product
Table 117. Roche Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 118. Roche Recent Development
Table 119. Hikma Pharmaceuticals Company Details
Table 120. Hikma Pharmaceuticals Business Overview
Table 121. Hikma Pharmaceuticals Anal Fistula Drugs Product
Table 122. Hikma Pharmaceuticals Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 123. Hikma Pharmaceuticals Recent Development
Table 124. TWi Pharmaceuticals Company Details
Table 125. TWi Pharmaceuticals Business Overview
Table 126. TWi Pharmaceuticals Anal Fistula Drugs Product
Table 127. TWi Pharmaceuticals Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 128. TWi Pharmaceuticals Recent Development
Table 129. Sanofi Company Details
Table 130. Sanofi Business Overview
Table 131. Sanofi Anal Fistula Drugs Product
Table 132. Sanofi Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 133. Sanofi Recent Development
Table 134. Sun Pharmaceutical Company Details
Table 135. Sun Pharmaceutical Business Overview
Table 136. Sun Pharmaceutical Anal Fistula Drugs Product
Table 137. Sun Pharmaceutical Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 138. Sun Pharmaceutical Recent Development
Table 139. Bristol Myers Company Details
Table 140. Bristol Myers Business Overview
Table 141. Bristol Myers Anal Fistula Drugs Product
Table 142. Bristol Myers Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 143. Bristol Myers Recent Development
Table 144. Akorn Company Details
Table 145. Akorn Business Overview
Table 146. Akorn Anal Fistula Drugs Product
Table 147. Akorn Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 148. Akorn Recent Development
Table 149. Dr. Reddys Company Details
Table 150. Dr. Reddys Business Overview
Table 151. Dr. Reddys Anal Fistula Drugs Product
Table 152. Dr. Reddys Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 153. Dr. Reddys Recent Development
Table 154. Lupin Company Details
Table 155. Lupin Business Overview
Table 156. Lupin Anal Fistula Drugs Product
Table 157. Lupin Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 158. Lupin Recent Development
Table 159. Advanz Pharmaceutical Company Details
Table 160. Advanz Pharmaceutical Business Overview
Table 161. Advanz Pharmaceutical Anal Fistula Drugs Product
Table 162. Advanz Pharmaceutical Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 163. Advanz Pharmaceutical Recent Development
Table 164. Aurobindo pharma Company Details
Table 165. Aurobindo pharma Business Overview
Table 166. Aurobindo pharma Anal Fistula Drugs Product
Table 167. Aurobindo pharma Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 168. Aurobindo pharma Recent Development
Table 169. Baxter International Company Details
Table 170. Baxter International Business Overview
Table 171. Baxter International Anal Fistula Drugs Product
Table 172. Baxter International Revenue in Anal Fistula Drugs Business (2016-2021) & (US$ Million)
Table 173. Baxter International Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anal Fistula Drugs Market Share by Type: 2020 VS 2027
Figure 2. Laxatives Features
Figure 3. Antibiotics Features
Figure 4. Topical Nitrates Features
Figure 5. Calcium Channel Blockers Features
Figure 6. OnabotulinumtoxinA Injections Features
Figure 7. Others Features
Figure 8. Global Anal Fistula Drugs Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Anal Fistula Drugs Report Years Considered
Figure 13. Global Anal Fistula Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Anal Fistula Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Anal Fistula Drugs Market Share by Regions: 2020 VS 2027
Figure 16. Global Anal Fistula Drugs Market Share by Regions (2022-2027)
Figure 17. Global Anal Fistula Drugs Market Share by Players in 2020
Figure 18. Global Top Anal Fistula Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anal Fistula Drugs as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Anal Fistula Drugs Revenue in 2020
Figure 20. Global Anal Fistula Drugs Revenue Market Share by Type (2016-2021)
Figure 21. Global Anal Fistula Drugs Revenue Market Share by Type (2022-2027)
Figure 22. North America Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Anal Fistula Drugs Market Share by Type (2016-2027)
Figure 24. North America Anal Fistula Drugs Market Share by Application (2016-2027)
Figure 25. North America Anal Fistula Drugs Market Share by Country (2016-2027)
Figure 26. United States Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Anal Fistula Drugs Market Share by Type (2016-2027)
Figure 30. Europe Anal Fistula Drugs Market Share by Application (2016-2027)
Figure 31. Europe Anal Fistula Drugs Market Share by Country (2016-2027)
Figure 32. Germany Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Anal Fistula Drugs Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Anal Fistula Drugs Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Anal Fistula Drugs Market Share by Region (2016-2027)
Figure 42. China Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Anal Fistula Drugs Market Share by Type (2016-2027)
Figure 50. Latin America Anal Fistula Drugs Market Share by Application (2016-2027)
Figure 51. Latin America Anal Fistula Drugs Market Share by Country (2016-2027)
Figure 52. Mexico Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Anal Fistula Drugs Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Anal Fistula Drugs Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Anal Fistula Drugs Market Share by Country (2016-2027)
Figure 58. Turkey Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Anal Fistula Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Pfizer Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 62. AbbVie Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 65. Mylan Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 66. Teva Pharmaceuticals Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 67. Bausch Health Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 68. Takeda Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 69. Kyowa Kirin (ProStrakan) Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 70. Boiron Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 71. Roche Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 72. Hikma Pharmaceuticals Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 73. TWi Pharmaceuticals Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 74. Sanofi Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 75. Sun Pharmaceutical Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 76. Bristol Myers Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 77. Akorn Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 78. Dr. Reddys Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 79. Lupin Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 80. Advanz Pharmaceutical Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 81. Aurobindo pharma Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 82. Baxter International Revenue Growth Rate in Anal Fistula Drugs Business (2016-2021)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
世界の痔瘻非外科治療市場規模・現状・予測（2021年-2027年） Anal fistula treatment involves use of both surgical and non-surgical approaches for effective removal of anal fistulae in patients. Non-surgical methods include drugs as well as fibrin glue injections, adipose stem cell therapy, and collagen paste. Market Analysis and Insights: Global Anal Fistula …- 世界の痔瘻外科治療市場規模・現状・予測（2021年-2027年） Anal fistula treatment involves use of both surgical and non-surgical approaches for effective removal of anal fistulae in patients. Surgical procedures include fistulotomy, bioprosthetic plugs, advancement flap procedures, seton techniques, and new techniques such as LIFT and FiLaC therapy. Market …
- 世界の膵液瘻治療市場規模・現状・予測（2021年-2027年） A pancreatic fistula is an abnormal communication between the pancreas and other organs due to leakage of pancreatic secretions from damaged pancreatic ducts. Market Analysis and Insights: Global Pancreatic Fistula Treatment Market The global Pancreatic Fistula Treatment market size is projected to …
- 世界の直腸膣瘻市場規模・現状・予測（2021年-2027年） A rectovaginal fistula is an abnormal connection between the lower portion of your large intestine — your rectum — and your vagina. Market Analysis and Insights: Global Rectovaginal Fistula Market The global Rectovaginal Fistula market size is projected to reach US$ 1092.8 million by 2027, from US$ …
- 世界の直腸膣瘻治療市場規模・現状・予測（2021年-2027年） Rectovaginal fistula is abnormal connection between lower portion of large intestine- rectum-vagina. There are various causes of rectovaginal fistula such as Crohn's disease, cancer or radiation treatment in pelvic area, surgery involving vagina, perineum, rectum or anus, injuries during childbirth,…